Pilot Trial of Hibiscus Drink During Pregnancy (PTHDDP)

Brief summary (registry, in English)

The goal of this phase I pilot clinical trial is to evaluate the acceptability, tolerability and effect on blood pressure and biomarkers of Hibiscus sabdariffa drink in pregnant women in the second trimester of pregnancy. The main questions it aims to answer are: Is the drink acceptable to take as a daily dose for a long time? Does drinking the beverage cause negative effects? What is the effect of drink consumption on blood pressure and biomarkers in pregnant women? Each participant was their own control with the values measured before consumption of the beverage and after four weeks of consumption. The participants: * Took a daily dose of the beverage for 4 weeks * Once a week for the four weeks, they answered the acceptability and tolerability questionnaires * Before starting to consume the beverage and after the 4 weeks of consumption, they had their blood pressure measured, and samples taken for biomarker measurements.

What you commit to

• Study type: Interventional
• Participants enrolled: 10
• From 30 Apr 2024 to the primary completion date, 30 Jun 2024
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to 35 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.